O'Brien, K. J. Et Al. 2018. Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis. MOLECULAR GENETICS AND METABOLISM , vol.125 , 168-173.

O'Brien, K. J., Introne, W. J., Akal, O., AKAL, T., Barbu, A., McGowan, M. P., ... Merideth, M. A.(2018). Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis. MOLECULAR GENETICS AND METABOLISM , vol.125, 168-173.

O'Brien, Kevin Et Al. "Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis," MOLECULAR GENETICS AND METABOLISM , vol.125, 168-173, 2018

O'Brien, Kevin J. Et Al. "Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis." MOLECULAR GENETICS AND METABOLISM , vol.125, pp.168-173, 2018

O'Brien, K. J. Et Al. (2018) . "Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis." MOLECULAR GENETICS AND METABOLISM , vol.125, pp.168-173.

@article{article, author={Kevin J. O'Brien Et Al. }, title={Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis}, journal={MOLECULAR GENETICS AND METABOLISM}, year=2018, pages={168-173} }